Abbott’s HUMIRA® (adalimumab) receives U.S. FDA approval for the treatment of adult patients with moderate to severe ulcerative colitis
The U.S. FDA has approved HUMIRA®...
28 September 2012 | By Abbott
The U.S. FDA has approved HUMIRA®...
List view / Grid view
The U.S. FDA has approved HUMIRA®...
28 September 2012 | By Abbott
The U.S. FDA has approved HUMIRA®...
Biogen Idec and Abbott announced additional results from the SELECT…
22 October 2011 | By Biogen Idec
Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial...